Education/Working Experience

Education Experience:

BSc in Clinical Pharmacy, Dalian Medical University, Dalian, P. R. China, 1993 to 1998

MSc in Pharmacology, Dalian Medical University, Dalian, P. R. China, 2000 to 2003
On-going doctoral research in Chinese & Western Combining Pharmacology,    Dalian Medical University, Now

Visiting Scholar, Stony Brook University School of Medicine, USA, 01/2015 to 06/2015

Working Experience:

Pharmacist , 08/1998 to 08/2003;

Pharmacy Supervisor, 09/2003 to 10/2008;

Deputy Pharmacy Director, 11/2008 to 11/2013;

Pharmacy Director, 12/2013 up to now.

Pharmacy department, The Second Hospital attached to Dalian Medical University, Dalian, China

Publication

（1）Wanqiu Li, Xia Lin, Zhenhua Yang, Wei Zhang, Tianyang Ren, Fengming Qu, Yanjiao Wang, Ning Zhang*, Xing Tang*，A bufadienolide-loaded submicron emulsion for oral administration: Stability, antitumor efficacy and toxicity.，Int J Pharm, 2015，79(1):52-62

（* corresponding author）

（2）Xin XL, Dong PP, Sun XH, Deng S,Zhang N, Wang C, Huo XK, Li Y, Lan R, Chen L, Fan GJ. Identification of the hydroxylated derivatives of bufalin: phase I metabolites in rats. J Asian Nat Prod Res.，2015，17(4):1-9

（3） Zeng W, Shan W, Gao L, Gao D, Hu Y, Wang G,Zhang N, Li Z, Tian X, Xu W, Peng J, Ma X, Yao J. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease. Sci Rep.，2015，3；5:16013

（4）Hu Y,Zhang N, Fan Q, Lin M, Zhang C, Fan G, Zhai X, Zhang F, Chen Z, Yao J. Protective efficacy of carnosic acid against hydrogen peroxide induced oxidative injury in HepG2 cells through the SIRT1 pathway，Can J Physiol Pharmacol. ，2015，93(8):625-31

Research Projects/Grants

1. Project sponsored by Science and Technology Department of Liaoning Province Government.

2012-2014 Project leader, Prepration of Long Circulating Liposomes Toad Venom and anti-tumor Mechanism  

2. Project sponsored by National Natural Science Foudation.

2015-2018 Project member, Carnosic acid alleviates alcohol-induced liver injury via miR-34a/SIRT1-p66shc pathway